Ahmad, 2005 - Google Patents
The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virusAhmad, 2005
- Document ID
- 14813171447690374067
- Author
- Ahmad N
- Publication year
- Publication venue
- Critical Reviews in Clinical Laboratory Sciences
External Links
Snippet
The vertical (mother-to-infant) transmission of human immunodeficiency virus type 1 (HIV-1) occurs at an estimated rate of more than 30% and is the major cause of AIDS in children. Numerous maternal parameters, including advanced clinical stages, low CD4+ lymphocyte …
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 291
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ahmad | The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus | |
Levy | The retroviridae | |
Lawn et al. | Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection | |
Ometto et al. | Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission | |
Mofenson | Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions | |
Haigwood et al. | Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile | |
Miyazawa et al. | The ‘immunologic advantage’of HIV-exposed seronegative individuals | |
Hirsch et al. | A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3 | |
Ahmad | Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells | |
Schwartz et al. | Current concepts in human immunodeficiency virus infection and AIDS | |
D'SOUZA et al. | Meeting Report: Early Phases of HIV Type 1 Infection1, 2, 3 | |
Ahmad | Maternal-fetal transmission of human immunodeficiency virus | |
Allison et al. | Feline immunodeficiency virus is concentrated in milk early in lactation | |
Schreiber et al. | Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum | |
Johnson et al. | Cellular immune responses to HIV-1 | |
Farquhar et al. | The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression | |
Kolenda-Roberts et al. | Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat | |
Guatelli et al. | Human immunodeficiency virus | |
Weiss et al. | Human immunodeficiency viruses | |
Rossi et al. | Mother‐to‐child transmission of human immunodeficiency virus | |
Azevedo-Pereira | HIV-2 interaction with target cell receptors, or why HIV-2 is less pathogenic than HIV-1 | |
Koning et al. | Biological and molecular aspects of HIV-1 coreceptor usage | |
Chen et al. | Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines | |
Hosie et al. | Feline Immunodeficiency Virus | |
Rocha | Analysis of antibody neutralization specificities in Human Immunodeficiency Virus Type 2 infection |